PoliticalRepoPoliticalRepo

United States · Bill · HR

H.R. 3666 (114th)

Scleroderma and Fibrosis Research Enhancement Act of 2015

referredUnited States· United States Congress· EN

Introduced

1 October 2015

Last action

2 October 2015 · Referred

Status

Referred to the Subcommittee on Health.

Sponsors

PETER KING, Rep. Capps, Lois [D-CA-24], Rep. Rangel, Charles B. [D-NY-19], Del. Norton, Eleanor Holmes [D-DC-At Large], JOSEPH CROWLEY, ELIOT ENGEL, James McGovern, Sam Graves, Billy Long, Rep. Fitzpatrick, Michael G. [R-PA-8], Steve Stivers, LOUISE SLAUGHTER, Rep. Hanna, Richard L. [R-NY-22], Rep. Tonko, Paul [D-NY-20], Ann Wagner, Bill Huizenga, Rep. Clarke, Yvette D. [D-NY-9], Rep. Israel, Steve [D-NY-3], Matt Cartwright, Hakeem Jeffries, Rep. Gibson, Christopher P. [R-NY-19], Sen. Welch, Peter [D-VT], Rep. Miller, Candice S. [R-MI-10], Ann Kuster, Ed Perlmutter, Rep. Pingree, Chellie [D-ME-1], Mark Takano, ALCEE HASTINGS, Kathleen Rice, Rep. Beatty, Joyce [D-OH-3], Bennie Thompson, Rep. Lieu, Ted [D-CA-36], Frederica Wilson, Anna Eshoo, Alan Lowenthal, RICHARD NOLAN, Mike Coffman, Rep. Lofgren, Zoe [D-CA-18], GENE GREEN, Sen. Schiff, Adam B. [D-CA], Brenda Lawrence, Daniel Kildee, Rep. Dold, Robert J. [R-IL-10], Rep. Dingell, Debbie [D-MI-6], Mark Sanford, Sean Maloney, John Delaney, Ann Kirkpatrick

Subjects

Healthcare

Source updated

3 December 2025

Healthcare

Official sourceDownload fileView documentsShare

Summary

Scleroderma and Fibrosis Research Enhancement Act of 2015 This bill requires the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) to establish the National Commission on Scleroderma and Fibrosis Research. (Scleroderma and fibrosis are connective tissue conditions that cause hardening or scarring of skin and organs.) The commission must develop a long-term, comprehensive plan for scleroderma and fibrosis research. The plan must: (1) prioritize research that has cross-cutting value and requires coordination across NIH, and (2) include specific steps for implementation of the research. The commission must establish working groups to make research recommendations for the various organs and systems impacted by fibrotic illness. The commission must be terminated not later than two years after establishment. The NIAMS must create the Scleroderma and Fibrosis Working Group to oversee and assist with implementation of the long-term plan.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

  1. 1 October 2015

    Introduced

    Referred to the House Committee on Energy and Commerce.

    Source: IntroReferral

  2. 1 October 2015

    Introduced

    Introduced in House

    Source: IntroReferral

  3. 1 October 2015

    Introduced

    Introduced in House

    Source: IntroReferral

  4. 2 October 2015

    Referred

    Referred to the Subcommittee on Health.

    Source: Committee

Votes

No vote records are attached yet.

Versions

Documents

3 official files

Introduced in House (text)

View fileDownload file

Sponsors

Showing 48 of 53 sponsors and actors.

Related records

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.